title: [High throughput screening of pharmacokinetics and metabolism in drug discovery (I)--establishment of assessment system for absorption to compounds with a wide diversity of physical properties].
abstract: The application of combinatorial chemistry and high-throughput screening to biological targets has led to efficient identification of lead compounds in wide therapeutic areas. However, the physicochemical properties of some lead compounds are lipophilic with low water soluble. Since these parameters determine in vivo absorption, we established robust screening methods for solubility and Caco-2 membrane permeability which are applicable to our screening strategy based on the structure-pharmacokinetic parameter relationship (SPR). Of test compounds with different core structures, turbidimetric solubility and apparent solubility as determined by HPLC-UV analysis after dilution of aqueous media from DMSO stock solution was overestimated in comparison with the corresponding thermodynamic solubility obtained using a traditional shake-flask method. A new powder-dissolution method providing thermodynamic solubility similar to that in the traditional method was developed using 96-well plates for equilibrium dialysis. The throughput of the method was the almost the same as that using the apparent solubility method. In a conventional Caco-2 assay, membrane permeability (P(app)) of some lipophilic compounds was underestimated due to low solubility in the apical site and adhesion to the device, resulting in a poor relationship between the in vivo absorption fraction and the P(app) values. The addition of 0.1% Gelucire 44/14 into the apical site and 4% bovine serum albumin into the basolateral site improved the relationship. These newly developed methods are therefore useful to optimize lead compounds with less water solubility and high lipophilicity on the basis of SPR.
authors.affiliation: Department of Research Pharmacokinetics, Research Center Kyoto, Bayer Yakuhin, Ltd., Kyoto 619-0216, Japan. hiroshi.komura.hk@bayer.co.jp
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Komura
authors.forename: Iichiro
authors.initials: I
authors.lastname: Kawahara
authors.forename: Yukie
authors.initials: Y
authors.lastname: Shigemoto
authors.forename: Kenichi
authors.initials: K
authors.lastname: Matsuda
authors.forename: Rieko
authors.initials: R
authors.lastname: Ano
authors.forename: Yoko
authors.initials: Y
authors.lastname: Murayama
authors.forename: Toshiya
authors.initials: T
authors.lastname: Moriwaki
authors.forename: Nagahiro H
authors.initials: NH
authors.lastname: Yoshida
mesh_terms: D000818:Animals; D002463:Cell Membrane Permeability; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D004121:Dimethyl Sulfoxide; D015195:Drug Design; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D008297:Male; D010599:Pharmacokinetics; D051381:Rats; D017208:Rats, Wistar; D012995:Solubility; D013329:Structure-Activity Relationship; D014867:Water
chemical_list: D014867:Water; D004121:Dimethyl Sulfoxide